Publications by Dr Anja Krippner-Heidenreich - ePrints

Browsing publications by Dr Anja Krippner-Heidenreich.

Newcastle Authors	Title	Year
Dr Anja Krippner-Heidenreich	TNF-α–induced protein 3 (TNFAIP3)/A20 acts as a master switch in TNF-α blockade–driven IL-17A expression	2018
Zak Gamie Dr Emma Haagensen Ricardo da Conceicao Ribeiro Professor Kenneth Dalgarno Dr Anja Krippner-Heidenreich et al.	TNF-related apoptosis-inducing ligand (TRAIL) for bone sarcoma treatment: Pre-clinical and clinical data	2017
Marilena Patsalidou Dr Amy Anderson Dr Anja Krippner-Heidenreich	An unconventional anti-inflammatory role for TNF recpetor (TNFR)1 in tregs: TNFR1 and 2 differetnialy modulate FOXP3+ TREG function	2014
Dr Nicola Maney Dr Gary Reynolds Dr Anja Krippner-Heidenreich Professor Catharien Hilkens	Dendritic Cell Maturation and Survival Are Differentially Regulated by TNFR1 and TNFR2	2014
Professor Jaap van Laar Dr Anja Krippner-Heidenreich	CLL cells are resistant to smac mimetics because of an inability to form a ripoptosome complex	2013
Dr Thomas Huegle Dr Steven O'Reilly Rachel Simpson Dr Venetia Bigley Professor Matthew Collin et al.	Tumor Necrosis Factor-Costimulated T Lymphocytes From Patients With Systemic Sclerosis Trigger Collagen Production in Fibroblasts	2013
Dr Steven O'Reilly Dr Bridget Griffiths Dr Anja Krippner-Heidenreich Professor Jaap Van Laar	T cell derived IL-6 and IL-13 drive fibroblast fibrosis: Implications for systemic sclerosis	2012
Dr Aaron Ions Gardner Professor Andrew Fisher Christine Richter Grace Johnson Dr Elizabeth Moisey et al.	The Critical Role of TAK1 in Accentuated Epithelial to Mesenchymal Transition in Obliterative Bronchiolitis after Lung Transplantation	2012
Simon Neumann Dr Anja Krippner-Heidenreich	The Transmembrane Domains of TNF-Related Apoptosis-Inducing Ligand (TRAIL) Receptors 1 and 2 Co-Regulate Apoptotic Signaling Capacity	2012
Christine Richter Professor Derek Mann Dr Anja Krippner-Heidenreich	The Tumor Necrosis Factor Receptor Stalk Regions Define Responsiveness to Soluble versus Membrane-Bound Ligand	2012
Dr Steven O'Reilly Dr Venetia Bigley Professor Matthew Collin Dr Anja Krippner-Heidenreich Professor Jaap van Laar et al.	Tumor necrosis factor-alpha co-activated T-cells support a profibrotic cytokine milieu on cost of IL-10 expression in patients with systemic sclerosis	2012
Dr Anja Krippner-Heidenreich	Analysis of ligand receptor interaction with new single chain TNF derivatives	2011
Dr Anja Krippner-Heidenreich	Ligand-induced internalization of TNF receptor 2 mediated by a di-leucin motif is dispensable for activation of the NFκB pathway	2011
Dr Steven O'Reilly Dr Thomas Huegle Dr Anja Krippner-Heidenreich Professor Jaap Van Laar	T cell-derived IL-6 and IL-13 drive dermal fibrosis: implications for systemic sclerosis	2011
Dr Anja Krippner-Heidenreich	The stalk region of the TNF receptors highly determines soluble TNF responsiveness	2011
Dr Thomas Huegle Dr Anja Krippner-Heidenreich Rachel Simpson Dr Steven O'Reilly Dr Venetia Bigley et al.	Tumour necrosis factor alpha receptor activated T cells of patients with systemic sclerosis are deficient in IL-10 expression but promote myofibroblast differentiation via IL-6 and TGF-beta	2011
Dr Anja Krippner-Heidenreich	Dual function of cysteine rich domain (CRD) 1 of TNF receptor type 1: conformational stabilization of CRD2 and control of receptor responsiveness	2010
Dr Anja Krippner-Heidenreich	Fluorescence correlation spectroscopy reveals topological segregation of the two tumor necrosis factor membrane receptors	2010
Dr Anja Krippner-Heidenreich	Potent antitumoral activity of TRAIL through generation of tumor-targeted single-chain fusion proteins	2010
Dr Nicola Maney Helen Baldwin Dr Anja Krippner-Heidenreich Professor Catharien Hilkens	Regulation of dendritic cell survival and function by tumour necrosis factor receptors 1 and 2	2010
Dr Anja Krippner-Heidenreich	Single chain TNF derivatives with individually mutated receptor binding sites reveal differential stoichiometry of ligand receptor complex formation for TNFR1 and TNFR2	2010
Dr Anja Krippner-Heidenreich	Nanoscale Arrangement of Apoptotic Ligands Reveals a Demand for a Minimal Lateral Distance for Efficient Death Receptor Activation	2009
Dr Anja Krippner-Heidenreich Dr Jason Gill	Single-Chain TNF, a TNF Derivative with Enhanced Stability and Antitumoral Activity	2008
Dr Anja Krippner-Heidenreich	Tumour necrosis factors (review)	2007
Dr Anja Krippner-Heidenreich	Caspase-dependent cleavage and subcellular redistribution of YY1 during apoptosis enhances proapoptotitic activity	2005
Dr Anja Krippner-Heidenreich	The Met196Arg variation of human TNFR2 affects TNF-induced apoptosis by impaired NF-B-signalling and target gene expression	2005
Dr Anja Krippner-Heidenreich	TNF-Funtionalized nanostructured particles for the stimulation of Membrane TNF-specific Cell responses	2005
Dr Anja Krippner-Heidenreich	[reviwe] FasL and Fas: typical members of the TNF ligand and receptor family	2004
Dr Anja Krippner-Heidenreich	Control of receptor-induced signaling complex formation by the kinetics of ligand/receptor interaction	2002
Dr Anja Krippner-Heidenreich	Targeting of the transcription factor Max during apoptosis: phosphorylation-regulated cleavage by caspase-5 at an unusual glutamic acid residue in position P1	2001
Dr Anja Krippner-Heidenreich	Inhibition of proliferation and apoptosis by the transcriptional repressor Mad1: Repression of Fas-induced caspase-8 activation	2000